A detailed history of Castle Rock Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Castle Rock Wealth Management, LLC holds 6,267 shares of AMGN stock, worth $1.95 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,267
Previous 5,984 4.73%
Holding current value
$1.95 Million
Previous $1.72 Million 3.37%
% of portfolio
0.49%
Previous 0.53%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $76,090 - $91,850
283 Added 4.73%
6,267 $1.78 Million
Q4 2023

Jan 08, 2024

BUY
$255.7 - $288.46 $15,853 - $17,884
62 Added 1.05%
5,984 $1.72 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $957,468 - $1.19 Million
4,379 Added 283.8%
5,922 $1.59 Million
Q2 2023

Jul 10, 2023

SELL
$214.27 - $253.37 $214 - $253
-1 Reduced 0.06%
1,543 $342,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $74,284 - $90,540
329 Added 27.08%
1,544 $373,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $36,186 - $45,979
158 Added 14.95%
1,215 $319,000
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $480,793 - $542,247
-2,142 Reduced 66.96%
1,057 $259,000
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.93%
3,199 $791,000
Q1 2022

Apr 25, 2022

SELL
$219.27 - $242.57 $929,485 - $1.03 Million
-4,239 Reduced 56.76%
3,229 $818,000
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $43,753 - $50,072
220 Added 3.04%
7,468 $1.7 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $1.32 Million - $1.55 Million
6,213 Added 600.29%
7,248 $1.53 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $5,839 - $6,478
-25 Reduced 2.36%
1,035 $236,000
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $3,106 - $3,620
-14 Reduced 1.3%
1,060 $270,000
Q4 2020

Jan 29, 2021

BUY
$216.38 - $257.67 $232,392 - $276,737
1,074 New
1,074 $272,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Castle Rock Wealth Management, LLC Portfolio

Follow Castle Rock Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.